Precision Diagnostics

The Apex Standard of Diagnostics

Precision diagnostics at Dr. Adin's practice reflects the same uncompromising standard of care delivered through our Apex Membership, the most comprehensive biological optimization program available in clinical medicine. Where conventional medicine evaluates perhaps 20-30 markers and compares them to broad population reference ranges designed to detect overt disease, our diagnostic protocols evaluate 350 or more biomarkers across metabolic, hormonal, inflammatory, nutritional, immunological, and epigenetic domains. The goal is not to determine whether you are "sick" but to identify precisely where your biology deviates from optimal function and to detect deteriorating trends years before clinical disease manifests. Every therapeutic decision, from peptide selection to hormonal dosing to supplement prescription, is derived from and validated against your diagnostic data.

Comprehensive Diagnostic Panels

Our core longevity bloodwork encompasses over 350 biomarkers, forming the most complete picture of your internal biology available outside of a research institution. Advanced metabolic panels assess fasting insulin, HOMA-IR, glycated hemoglobin, fructosamine, and oral glucose tolerance to detect insulin resistance years before fasting glucose becomes abnormal. Cardiovascular risk profiling uses advanced lipid particle analysis, lipoprotein(a), apolipoprotein B, high-sensitivity CRP, oxidized LDL, and TMAO to stratify risk far beyond standard cholesterol testing. Full hormonal panels include free and bound fractions of all major hormones, with DUTCH test analysis for comprehensive hormone metabolite profiling including estrogen metabolite pathways critical for cancer risk assessment. Inflammatory panels measure cytokines (IL-6, TNF-alpha, IL-1beta), acute phase reactants, and specialized pro-resolving mediators. Nutritional status is assessed through intracellular micronutrient testing, essential fatty acid profiles, amino acid analysis, and organic acid testing.

Epigenetic and Genetic Testing

Biological age testing through DNA methylation analysis represents the most powerful tool in our diagnostic arsenal. We utilize the most validated epigenetic clocks including GrimAge and DunedinPACE to determine not just your current biological age but the rate at which you are aging. These results serve as the primary outcome measure for all longevity interventions, providing objective evidence of whether your protocol is producing measurable biological rejuvenation. Mitochondrial and genetic testing reveals inherited predispositions and current mitochondrial function, guiding the selection of targeted interventions. Multi-cancer detection screening uses advanced blood-based analysis to identify cancer signals at the earliest possible stage, when intervention is most effective.

Functional and Specialized Assessments

Beyond blood-based testing, our diagnostic suite includes toxin burden analysis to quantify exposure to heavy metals and environmental contaminants, autoimmune screening panels for early detection of immune dysregulation, gut health assessment through microbiome sequencing and organic acid testing, and allergy testing against 300+ allergens. Cardiovascular function is assessed through cardiologic stress testing and VO2 Max assessment, providing direct measurement of aerobic capacity and cardiovascular reserve. Wearable devices including the Oura ring and Whoop band provide continuous data on sleep architecture, heart rate variability, recovery status, and activity levels, creating a real-time feedback loop that enriches quarterly lab-based testing.

The Science of Precision Diagnosis

Research published in Nature Medicine demonstrates that multi-omic profiling, combining genomic, proteomic, metabolomic, and epigenomic data, identifies disease risk and biological aging trajectories with far greater accuracy than any single marker. The Framingham Heart Study established that traditional risk factors capture only 50-60% of cardiovascular disease risk, leaving a substantial portion unexplained by standard testing. Advanced lipid testing research from the MESA study confirms that LDL particle number and lipoprotein(a) are superior predictors of cardiovascular events compared to standard LDL cholesterol. Epigenetic clock research demonstrates that biological age, as measured by DNA methylation, predicts all-cause mortality, cancer incidence, and cognitive decline independently of chronological age.

What the Patient Can Expect

The diagnostic process begins with a detailed intake consultation reviewing medical history, family history, current symptoms, lifestyle factors, and optimization goals. Initial blood draws are fasted and comprehensive. Epigenetic testing requires a simple saliva or blood sample. DUTCH testing involves dried urine collection over a 24-hour period. Results are compiled into a detailed report and reviewed during a dedicated consultation (typically 60-90 minutes) where Dr. Adin explains each finding, identifies areas of concern and opportunity, and outlines the intervention strategy. Patients receive a clear, prioritized roadmap with specific therapeutic targets and timelines. Follow-up testing occurs quarterly for active optimization and biannually for maintenance, creating a longitudinal dataset that reveals your biological trajectory over time.

References

1. Schussler-Fiorenza Rose SM, et al. "A longitudinal big data approach for precision health." Nature Medicine, 2019;25:792-804.
2. Mora S, et al. "LDL particle number and risk of CVD in the MESA study." Circulation, 2007;115(6):717-724.
3. Horvath S, Raj K. "DNA methylation-based biomarkers and the epigenetic clock theory of aging." Nature Reviews Genetics, 2018;19:371-384.
4. Ohlsson C, et al. "Epigenetic aging and risk of disease." Clinical Chemistry, 2019;65(12):1483-1491.
5. Klein ME, et al. "Multi-cancer early detection blood testing." Annals of Oncology, 2021;32(12):1576-1585.